Home > Marketing > Polymerase Chain Reaction (PCR) Market Poised to Garner Maximum Revenues of US$ 9.6 Bn During 2014-2

Polymerase Chain Reaction (PCR) Market Poised to Garner Maximum Revenues of US$ 9.6 Bn During 2014-2

Added: (Wed Dec 06 2017)

Pressbox (Press Release) -

Transparency Market Research (TMR) has recently published a market study on the global polymerase chain reaction (PCR) market, stating that the global market stood at US$6.1 bn in 2013. Analysts at TMR estimate it to rise at a CAGR of 6.60% during the period from 2014 to 2020 and reach a value of US$9.6 bn by the end of the forecast period.The research report is titled “Polymerase Chain Reaction (PCR) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”

According to the research report, the rising demand for highly advanced molecular diagnostic techniques to detect severe diseases accurately is the key factor behind the remarkable growth of the PCR market in the global arena. The continued research and development activities in the field of diagnostic techniques are also stimulating this market significantly.

Further, the report states that the worldwide PCR market is witnessing a rapid rise in public as well as private funding, which has prompted PCR-based drug discovery and the research activities on genomics. The production of customized medicines and the demand for automated devices have also been reporting a rise in recent years, boosting the global PCR market.

Read Report Overview @ https://www.transparencymarketresearch.com/pcr-technologies.html

The report studies the worldwide PCR market on the basis of product, application, end use, and the regional distribution of this market. Based on product, the market has been classified into instruments and reagents and consumables. The reagents and consumables segment led the global PCR market with a share of 67%, amounting to US$4 bn in 2013.

By application, the market has been categorized into clinical diagnostics, life sciences, and other application. The life sciences segment dominated the global PCR market with a share of 48% in 2013.

By end use, the report segments the global PCR market into clinical diagnostics labs and hospitals, academic and research organizations, and the pharmaceutical and biotechnology industries. In 2013, the academics and research organizations segment emerged as the biggest end user of polymerase chain reactions across the world, says the study.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

Regionally, the report divides the global PCR market into North America, Asia Pacific, Europe, and the Rest of the World. Among these, North America emerged as the leading regional market in 2013 with a total value of US$2.6 bn. Analysts project it to reach a value of US$3.9 bn by the end of the forecast period. Asia Pacific, on the other hand, is estimated to register the highest growth rate among all the regional markets over the forecast period, states the report.

The study reports that the worldwide PCR market is concentrated in nature. Sigma-Aldrich Co., F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., Becton, Dickinson & Co., Affymetrix Inc., Bio-Rad Laboratories Inc., GE Healthcare, Abbott Laboratories, QIAGEN, Thermo Fisher Scientific Inc., and Agilent Technologies Inc. are some of the key market participants mentioned in this report.

Submitted by:Shashii Pawar
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.